Barclays’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
Other funds holding INGN
Barclays's INGN Position: Q3 2026 in Review
Barclays increased its Inogen (INGN) stake by 13% in Q3 2026, buying an estimated $33.7K and bringing the position to 48,334 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #3826.
Barclays first reported a position in INGN in Q1 2014 and has held it in 51 quarters since. The position peaked at $3.79M in Q4 2015. 61 funds tracked by Wall St. Rank hold INGN as of Q3 2026.
- Barclays held 48,334 shares of Inogen worth $255K as of Q3 2026.
- Barclays bought 5,727 Inogen shares in Q3 2026, an estimated $33.7K.
- Inogen made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3826 holding.
- Barclays first reported a position in Inogen in Q1 2014 and has held it in 51 quarters since.
- Barclays's Inogen position peaked at $3.79M in Q4 2015.
- 61 funds tracked by Wall St. Rank held Inogen as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.